{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:41:35Z","timestamp":1791218495859,"version":"4.1.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s40263-018-0525-5","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T06:46:22Z","timestamp":1526280382000},"page":"421-435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review"],"prefix":"10.1007","volume":"32","author":[{"given":"MacKenzie R.","family":"Peltier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Sofuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"525_CR1","unstructured":"United Nations Office on Drugs and Crime (UNODC). World drug report 2017. 2017. Available from: http:\/\/www.unodc.org\/wdr2017\/ . Accessed 27 Dec 2017."},{"key":"525_CR2","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"GBD 2016 Causes of Death Collaborators","year":"2017","unstructured":"GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151\u2013210.","journal-title":"Lancet"},{"key":"525_CR3","unstructured":"National Institute of Drug Abuse (NIDA). Health consequences of drug misuse. 2017. Available from: https:\/\/www.drugabuse.gov\/related-topics\/health-consequences-drug-misuse . Accessed 6 Oct 2017."},{"key":"525_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","volume":"73","author":"BF Grant","year":"2016","unstructured":"Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, Zhang H, Smith SM, Pickering RP, Huang B, Hasin DS. Epidemiology of DSM-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions. III. JAMA Psychiatry. 2016;73:39\u201347.","journal-title":"JAMA Psychiatry."},{"key":"525_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00213-001-0944-7","volume":"159","author":"S Evans","year":"2002","unstructured":"Evans S, Haney M, Foltin R. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology. 2002;159:397\u2013406.","journal-title":"Psychopharmacology"},{"key":"525_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11920-014-0511-7","volume":"16","author":"MM Moran-Santa Maria","year":"2014","unstructured":"Moran-Santa Maria MM, Flanagan J, Brady K. Ovarian hormones and drug abuse. Curr Psychiatry Rep. 2014;16:511.","journal-title":"Curr Psychiatry Rep"},{"key":"525_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.psyneuen.2010.07.005","volume":"36","author":"M Sofuoglu","year":"2011","unstructured":"Sofuoglu M, Mouratidis M, Mooney M. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology. 2011;36:123\u201332.","journal-title":"Psychoneuroendocrinology"},{"key":"525_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1037\/1064-1297.7.3.274","volume":"7","author":"M Sofuoglu","year":"1999","unstructured":"Sofuoglu M, Dudish-Poulsen S, Nelson D, Pentel PR, Hatsukami DK. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharm. 1999;7:274\u201383.","journal-title":"Exp Clin Psychopharm"},{"key":"525_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1037\/a0021265","volume":"18","author":"WJ Lynch","year":"2010","unstructured":"Lynch WJ, Sofuoglu M. Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharm. 2010;18:451\u201361.","journal-title":"Exp Clin Psychopharm"},{"key":"525_CR10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.31887\/DCNS.2016.18.4\/jbecker","volume":"18","author":"JB Becker","year":"2016","unstructured":"Becker JB. Sex differences in addiction. Dial Clin Neurosci. 2016;18:395\u2013402.","journal-title":"Dial Clin Neurosci"},{"key":"525_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yfrne.2007.07.003","volume":"29","author":"JB Becker","year":"2008","unstructured":"Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrinol. 2008;29:36\u201347.","journal-title":"Front Neuroendocrinol"},{"key":"525_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.physbeh.2017.10.005","volume":"187","author":"AL Riley","year":"2018","unstructured":"Riley AL, Hempel BJ, Clasen MM. Sex as a biological variable: drug use and abuse. Physiol Behav. 2018;187:79\u201396.","journal-title":"Physiol Behav"},{"key":"525_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s002130050979","volume":"144","author":"WJ Lynch","year":"1999","unstructured":"Lynch WJ, Carroll ME. Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology. 1999;144:77\u201382.","journal-title":"Psychopharmacology"},{"key":"525_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pbb.2016.08.001","volume":"152","author":"BM Priddy","year":"2017","unstructured":"Priddy BM, Carmack SA, Thomas LC, Vendruscolo JCM, Koob GF, Vendruscolo LF. Sex, strain, and estrous cycle influences on alcohol drinking in rats. Pharmacol Biochem Behav. 2017;152:6\u201367.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2017.03.005","volume":"156","author":"PA Randall","year":"2017","unstructured":"Randall PA, Stewart RT, Besheer J. Sex differences in alcohol self-administration and relapse-like behavior in Long-Evans rats. Pharmacol Biochem Behav. 2017;156:1\u20139.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0091-3057(02)01039-0","volume":"74","author":"TJ Cicero","year":"2003","unstructured":"Cicero TJ, Aylward SC, Meyer ER. Gender differences in the intravenous self-administration of mu opiate agonists. Pharmacol Biochem Behav. 2003;74:541\u20139.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s002130000497","volume":"151","author":"E Donny","year":"2000","unstructured":"Donny E, Caggiula A, Rowell P, Gharib M, Maldovan V, Booth S, Mielke MM, Hoffman A, Mccallum S. Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology. 2000;151:392\u2013405.","journal-title":"Psychopharmacology"},{"key":"525_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.neubiorev.2004.08.001","volume":"28","author":"ME Roth","year":"2004","unstructured":"Roth ME, Cosgrove KP, Carroll ME. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci Biobehav Rev. 2004;28:533\u201346.","journal-title":"Neurosci Biobehav Rev"},{"key":"525_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s002130050042","volume":"148","author":"WJ Lynch","year":"2000","unstructured":"Lynch WJ, Carroll ME. Reinstatement of cocaine self-administration in rats: sex differences. Psychopharmacology. 2000;148:196\u2013200.","journal-title":"Psychopharmacology"},{"key":"525_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.npp.1300389","volume":"29","author":"WJ Lynch","year":"2004","unstructured":"Lynch WJ, Taylor JR. Sex differences in the behavioral effects of 24-h access to cocaine under a discrete trial procedure. Neuropsychopharmacology. 2004;29:943\u201351.","journal-title":"Neuropsychopharmacology"},{"key":"525_CR21","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s00213-016-4278-x","volume":"233","author":"ML Bertholomey","year":"2016","unstructured":"Bertholomey ML, Nagarajan V, Torregrossa MM. Sex differences in reinstatement of alcohol seeking in response to cues and yohimbine in rats with and without a history of adolescent corticosterone exposure. Psychopharmacology. 2016;233:2277\u201387.","journal-title":"Psychopharmacology"},{"key":"525_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00213-011-2187-6","volume":"216","author":"MW Feltenstein","year":"2011","unstructured":"Feltenstein MW, Henderson AR, See RE. Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle. Psychopharmacology. 2011;216:53\u201362.","journal-title":"Psychopharmacology"},{"key":"525_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s00213-004-2080-7","volume":"179","author":"RA Fuchs","year":"2004","unstructured":"Fuchs RA, Evans KA, Mehta RH, Case JM, See RE. Influence of sex and estrous cyclicity on conditioned cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology. 2004;179:662\u201372.","journal-title":"Psychopharmacology"},{"key":"525_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.drugalcdep.2011.07.010","volume":"120","author":"NA Holtz","year":"2012","unstructured":"Holtz NA, Lozama A, Prisinzano TE, Carroll ME. Reinstatement of methamphetamine seeking in male and female rats treated with modafinil and allopregnanolone. Drug Alcohol Depend. 2012;120:233\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"525_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainresbull.2011.03.001","volume":"85","author":"NE Gentile","year":"2011","unstructured":"Gentile NE, Andrewkanic JD, Karwoski TE, Czambel RK, Rubin RT, Rhodes ME. Sexually diergic hypothalamic\u2013pituitary\u2013adrenal (HPA) responses to single-dose nicotine, continuous nicotine infusion, and nicotine withdrawal by mecamylamine in rats. Brain Res Bull. 2011;85:145\u201352.","journal-title":"Brain Res Bull"},{"key":"525_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbr.2012.02.048","volume":"231","author":"LC Hart-Hargrove","year":"2012","unstructured":"Hart-Hargrove LC, Dow-Edwards DL. Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. Behav Brain Res. 2012;231:48\u201359.","journal-title":"Behav Brain Res"},{"key":"525_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00213-008-1089-8","volume":"198","author":"KA Kerstetter","year":"2008","unstructured":"Kerstetter KA, Aguilar VR, Parrish AB, Kippin TE. Protracted time-dependent increases in cocaine-seeking behavior during cocaine withdrawal in female relative to male rats. Psychopharmacology. 2008;198:63\u201375.","journal-title":"Psychopharmacology"},{"key":"525_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0091-3057(03)00017-0","volume":"73","author":"V Bisagno","year":"2003","unstructured":"Bisagno V, Fergunson D, Luine VN. Chronic D-amphetamine induces sexually dimorphic effects on locomotion, recognition memory, and brain monoamines. Pharmacol Biochem Behav. 2003;73:859\u201367.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0091-3057(02)00740-2","volume":"72","author":"TJ Cicero","year":"2002","unstructured":"Cicero TJ, Nock B, Meyer ER. Gender-linked differences in the expression of physical dependence in the rat. Pharmacol Biochem Behav. 2002;72:691\u20137.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/alcalc\/agp049","volume":"44","author":"W Reilly","year":"2008","unstructured":"Reilly W, Koirala B, Devaud LL. Sex differences in acoustic startle responses and seizure thresholds between ethanol-withdrawn male and female rats. Alcohol Alcohol. 2008;44:561\u20136.","journal-title":"Alcohol Alcohol"},{"key":"525_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.ALC.0000108655.51087.DF","volume":"28","author":"E Varlinskay","year":"2004","unstructured":"Varlinskay E, Spear LP. Acute ethanol withdrawal (hangover) and social behavior in adolescent and adult male and female Sprague\u2013Dawley rats. Alcohol Clin Exp Res. 2004;28:40\u201350.","journal-title":"Alcohol Clin Exp Res"},{"key":"525_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ogc.2014.02.001","volume":"41","author":"RK McHugh","year":"2014","unstructured":"McHugh RK, Wigderson S, Greenfield SF. Epidemiology of substance use in reproductive-age women. Obstet Gynecol Clin North Am. 2014;41:177\u201389.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"525_CR33","first-page":"1205","volume":"65","author":"Centers for Disease Control and Prevention (CDC)","year":"2016","unstructured":"Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults: United States, 2005\u20132015. Morb Mortal Wkly Rep. 2016;65:1205\u201311.","journal-title":"Morb Mortal Wkly Rep"},{"key":"525_CR34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","volume":"72","author":"BF Grant","year":"2015","unstructured":"Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 2015;72:757\u201366.","journal-title":"JAMA Psychiatry"},{"key":"525_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.drugalcdep.2014.10.003","volume":"145","author":"B Lewis","year":"2014","unstructured":"Lewis B, Hoffman LA, Nixon SJ. Sex differences in drug use among polysubstance users. Drug Alcohol Depend. 2014;145:127\u201333.","journal-title":"Drug Alcohol Depend"},{"key":"525_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/acer.12228","volume":"38","author":"B Lewis","year":"2014","unstructured":"Lewis B, Nixon SJ. Characterizing gender differences in treatment seekers. Alcoholism Clin Exp Res. 2014;38:275\u201384.","journal-title":"Alcoholism Clin Exp Res."},{"key":"525_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2165\/00023210-200115050-00005","volume":"15","author":"KA Perkins","year":"2001","unstructured":"Perkins KA. Smoking cessation in women. CNS Drugs. 2001;15:391\u2013411.","journal-title":"CNS Drugs"},{"key":"525_CR38","unstructured":"Substance Abuse and Mental Health Service Administration (SAMSHA). Chapter 3. Physiological effects of alcohol, drugs, and tobacco on women. In: Substance abuse treatment: addressing the specific needs of women (Treatment Improvement Protocol, No. 5). 2009. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83244\/ . Accessed 5 May 2018."},{"key":"525_CR39","unstructured":"National Institute of Drug Abuse (NIDA). Substance use in women. 2016. Available from: https:\/\/www.drugabuse.gov\/publications\/research-reports\/substance-use-in-women . Accessed 9 Oct 2017."},{"key":"525_CR40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/10550887.2012.735566","volume":"31","author":"M Terplan","year":"2012","unstructured":"Terplan M, McNamara EJ, Chisolm MS. Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt. J Addict Dis. 2012;31:342\u20139.","journal-title":"J Addict Dis"},{"key":"525_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.neubiorev.2010.05.001","volume":"35","author":"A Hudson","year":"2011","unstructured":"Hudson A, Stamp JA. Ovarian hormones and propensity to drug relapse: a review. Neurosci Biobehav Rev. 2011;35:427\u201336.","journal-title":"Neurosci Biobehav Rev"},{"key":"525_CR42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1037\/1064-1297.4.2.166","volume":"4","author":"KA Perkins","year":"1996","unstructured":"Perkins KA. Sex differences in nicotine versus nonnicotine reinforcement as determinants of tobacco smoking. Exp Clin Psychopharm. 1996;4:166\u201377.","journal-title":"Exp Clin Psychopharm"},{"key":"525_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.psc.2010.01.004","volume":"33","author":"SF Greenfield","year":"2010","unstructured":"Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin N Am. 2010;33:339\u201355.","journal-title":"Psychiatr Clin N Am"},{"key":"525_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/ntr\/ntu280","volume":"17","author":"TL Verplaetse","year":"2015","unstructured":"Verplaetse TL, Weinberger AH, Smith PH, Cosgrove KP, Mineur YS, Picciotto MR, Mazure CM, McKee SA. Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence. Nicotine Tob Res. 2015;17:486\u201395.","journal-title":"Nicotine Tob Res"},{"key":"525_CR45","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1521-0391.2011.00203.x","volume":"1","author":"AH Weinberger","year":"2012","unstructured":"Weinberger AH, McKee SA, George TP. Smoking cue reactivity in adult smokers with and without depression: a pilot study. Am J Addict. 2012;1:136\u201344.","journal-title":"Am J Addict"},{"key":"525_CR46","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1176\/appi.ajp.2011.11020289","volume":"169","author":"MN Potenza","year":"2012","unstructured":"Potenza MN, Hong KA, Lacadie CM, Fulbright RK, Tuit KL, Sinha R. Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence. Am J Psychiatry. 2012;169:406\u201314.","journal-title":"Am J Psychiatry"},{"key":"525_CR47","doi-asserted-by":"publisher","first-page":"16851","DOI":"10.1523\/JNEUROSCI.3661-14.2014","volume":"34","author":"KP Cosgrove","year":"2014","unstructured":"Cosgrove KP, Wang S, Kim S, McGovern E, Nabulsi N, Gao H, Labaree D, Tagare HD, Sullivan JM, Morris ED. Sex differences in the brain\u2019s dopamine signature of cigarette smoking. J Neurosci. 2014;34:16851\u20135.","journal-title":"J Neurosci"},{"issue":"3","key":"525_CR48","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1521-0391.2012.00232.x","volume":"21","author":"ME Saladin","year":"2012","unstructured":"Saladin ME, Gray KM, Carpenter MJ, LaRowe SD, DeSantis SM, Upadhyaya HP. Gender differences in craving and cue reactivity to smoking and negative affect\/stress cues. Am J Addict. 2012;21(3):210\u201320.","journal-title":"Am J Addict"},{"issue":"3","key":"525_CR49","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1037\/a0027280","volume":"26","author":"M Nakajima","year":"2012","unstructured":"Nakajima M, Al\u2019Absi M. Predictors of risk for smoking relapse in men and women: a prospective examination. Psychol Addict Behav. 2012;26(3):633\u20137.","journal-title":"Psychol Addict Behav"},{"issue":"1\u20132","key":"525_CR50","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.drugalcdep.2007.07.015","volume":"93","author":"MM Husky","year":"2008","unstructured":"Husky MM, Mazure CM, Paliwal P, McKee SA. Gender differences in the comorbidity of smoking behavior and major depression. Drug Alcohol Depend. 2008;93(1\u20132):176\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"525_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/ntr\/ntr198","volume":"14","author":"AH Weinberger","year":"2012","unstructured":"Weinberger AH, McKee SA. Gender sifferences in smoking following an implicit mood induction. Nicotine Tob Res. 2012;14(5):621\u20135.","journal-title":"Nicotine Tob Res"},{"key":"525_CR52","doi-asserted-by":"publisher","unstructured":"Perkins KA, Karlitz JL, Kunkle N. Sex differences in subjective responses to moderate versus very low nicotine content cigarettes. Nicotine Tob Res. 2017. https:\/\/doi.org\/10.1093\/ntr\/ntx205 . Epub ahead of print.","DOI":"10.1093\/ntr\/ntx205"},{"key":"525_CR53","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.addbeh.2013.06.016","volume":"38","author":"EE Hartwell","year":"2013","unstructured":"Hartwell EE, Ray LA. Sex moderates stress reactivity in heavy drinkers. Addict Behav. 2013;38:2643\u20136.","journal-title":"Addict Behav"},{"key":"525_CR54","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/npp.2013.339","volume":"39","author":"EE DeVito","year":"2014","unstructured":"DeVito EE, Herman AI, Waters AJ, Valentine GW, Sofuoglu M. Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase. Neuropsychopharmacology. 2014;39:1431\u201340.","journal-title":"Neuropsychopharmacology"},{"key":"525_CR55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/hup.1055","volume":"24","author":"M Sofuoglu","year":"2009","unstructured":"Sofuoglu M, Mitchell E, Mooney M. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers. Hum Psychopharmacol (Berl). 2009;24:559\u201364.","journal-title":"Hum Psychopharmacol (Berl)"},{"key":"525_CR56","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/13685530400004199","volume":"7","author":"M Oettel","year":"2004","unstructured":"Oettel M, Mukhopadhyay AK. Progesterone: the forgotten hormone in men? Aging Male. 2004;7:236\u201357.","journal-title":"Aging Male"},{"key":"525_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jsbmb.2014.09.001","volume":"146","author":"R Guennoun","year":"2015","unstructured":"Guennoun R, Labombarda F, Gonzalez Deniselle MC, Liere P, De Nicola AF, Schumacher M. Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection. J Steroid Biochem Mol Biol. 2015;146:48\u201361.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"525_CR58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","volume":"186","author":"DS Reddy","year":"2010","unstructured":"Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113\u201337.","journal-title":"Prog Brain Res"},{"key":"525_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fnins.2013.00159","volume":"7","author":"M Singh","year":"2013","unstructured":"Singh M, Su C, Ng S. Non-genomic mechanisms of progesterone action in the brain. Front Neurosci. 2013;7:159.","journal-title":"Front Neurosci"},{"key":"525_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0166-4328(99)00081-9","volume":"1","author":"M Schumacher","year":"1999","unstructured":"Schumacher M, Coirini H, Robert F, Guennoun R, El-Etr M. Genomic and membrane actions of progesterone: Implications for reproductive physiology and behavior. Behav Brain Res. 1999;1:37\u201352.","journal-title":"Behav Brain Res"},{"key":"525_CR61","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1476-5381.2010.01059.x","volume":"162","author":"S Turkmen","year":"2011","unstructured":"Turkmen S, Backstrom T, Wahlstrom G, Andreen L, Johansson I. Tolerance to allopregnanolone with focus on the GABA-A receptor. Br J Pharmacol. 2011;162:311\u201327.","journal-title":"Br J Pharmacol"},{"key":"525_CR62","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.bcp.2007.07.011","volume":"74","author":"D Bertrand","year":"2007","unstructured":"Bertrand D, Gopalakrishnan M. Allosteric modulation of nicotinic acetylcholine receptors. Biochem Pharmacol. 2007;74:1155\u201363.","journal-title":"Biochem Pharmacol"},{"key":"525_CR63","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1601-183X.2009.00476.x","volume":"8","author":"D Gangitano","year":"2009","unstructured":"Gangitano D, Salas R, Teng Y, Perez E, De Biasi M. Progesterone modulation of \u03b15 nAChR subunits influences anxiety-related behavior during estrus cycle. Genes Brain Behav. 2009;8:398\u2013406.","journal-title":"Genes Brain Behav"},{"key":"525_CR64","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.bcp.2011.04.020","volume":"82","author":"A Pandya","year":"2011","unstructured":"Pandya A, Yakel JL. Allosteric modulators of the \u03b14\u03b22 subtype of neuronal nicotinic acetylcholine receptors. Biochem Pharmacol. 2011;82:952\u20138.","journal-title":"Biochem Pharmacol"},{"key":"525_CR65","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnins.2013.00164","volume":"7","author":"SL Petersen","year":"2013","unstructured":"Petersen SL, Intlekofer KA, Moura-Conlon PJ, Brewer DN, Del Pino Sans J, Lopez JA. Novel progesterone receptors: neural localization and possible functions. Front Neurosci. 2013;7:164.","journal-title":"Front Neurosci"},{"key":"525_CR66","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molmed.2012.12.007","volume":"19","author":"J Cui","year":"2013","unstructured":"Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during ageing: from periphery to brain. Trends Mol Med. 2013;19:197\u2013209.","journal-title":"Trends Mol Med"},{"key":"525_CR67","first-page":"99","volume-title":"Women and addiction: a comprehensive handbook","author":"TA Pigott","year":"2009","unstructured":"Pigott TA, Walker MH, Teitelbaum SA, Lu C. Sex differences and neurotransmitter systems in addiction. In: Brady KT, Back SE, Greenfield SF, editors. Women and addiction: a comprehensive handbook. New York (NY): The Guilford Press; 2009. p. 99\u2013117."},{"key":"525_CR68","doi-asserted-by":"crossref","unstructured":"Hall JE. Neuroendocrine control of the menstrual cycle. In: Strauss JF. Barbieri RL, editors. Yen and Jaffe\u2019s reproductive endocrinology, physiology, pathology, and clinical management, 6th edn. Philadelphia (PA): Elsevier; 2009. p. 139\u201354.","DOI":"10.1016\/B978-1-4160-4907-4.00007-3"},{"key":"525_CR69","doi-asserted-by":"crossref","unstructured":"Carmina E, Lobo RA. Evaluation of hormonal status. In: Strauss JF. Barbieri RL, editors. Yen and Jaffe\u2019s reproductive endocrinology, physiology, pathology, and clinical management, 6th ed. Philadelphia (PA): Sauders Elsevier; 2009: p. 801\u201324.","DOI":"10.1016\/B978-1-4160-4907-4.00032-2"},{"key":"525_CR70","volume-title":"Knobil and Neill\u2019s physiology of reproduction","author":"E Knobil","year":"2006","unstructured":"Knobil E, Neill JD. Knobil and Neill\u2019s physiology of reproduction. 3rd ed. Boston (MA): Elsevier; 2006.","edition":"3"},{"key":"525_CR71","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.psyneuen.2016.08.019","volume":"74","author":"J Sun","year":"2016","unstructured":"Sun J, Walker AJ, Dean B, Van den Buuse M, Gogos A. Progesterone: the neglected hormone in schizophrenia? A focus on progesterone\u2013dopamine interactions. Psychoneuroendocrinology. 2016;74:126\u201340.","journal-title":"Psychoneuroendocrinology"},{"key":"525_CR72","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0091-3057(01)00455-5","volume":"68","author":"WJ Lynch","year":"2001","unstructured":"Lynch WJ, Roth ME, Mickelberg JL, Carroll ME. Role of estrogen in the acquisition of intravenously self-administered cocaine in female rats. Pharmacol Biochem Behav. 2001;68:641\u20136.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.npp.1300778","volume":"31","author":"LR Jackson","year":"2005","unstructured":"Jackson LR, Robinson TE, Becker JB. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology. 2005;31:129\u201338.","journal-title":"Neuropsychopharmacology"},{"key":"525_CR74","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1037\/1064-1297.15.5.472","volume":"15","author":"JJ Anker","year":"2007","unstructured":"Anker JJ, Larson EB, Gliddon LA, Carroll ME. Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats. Exp Clin Psychopharm. 2007;15:472\u201380.","journal-title":"Exp Clin Psychopharm"},{"key":"525_CR75","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yhbeh.2009.10.003","volume":"58","author":"NK Mello","year":"2010","unstructured":"Mello NK. Hormones, nicotine, and cocaine: clinical studies. Horm Behav. 2010;58:57\u201371.","journal-title":"Horm Behav"},{"key":"525_CR76","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00213-016-4345-3","volume":"233","author":"JR Smethells","year":"2016","unstructured":"Smethells JR, Swalve NL, Eberly LE, Carroll ME. Sex differences in the reduction of impulsive choice (delay discounting) for cocaine in rats with atomoxetine and progesterone. Psychopharmacology. 2016;233:2999\u20133008.","journal-title":"Psychopharmacology"},{"key":"525_CR77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.yhbeh.2009.10.001","volume":"58","author":"ME Carroll","year":"2010","unstructured":"Carroll ME, Anker JJ. Sex differences and ovarian hormones in animal models of drug dependence. Horm Behav. 2010;58:44\u201356.","journal-title":"Horm Behav"},{"key":"525_CR78","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1360-0443.2008.02146.x","volume":"103","author":"SS Allen","year":"2008","unstructured":"Allen SS, Bade T, Center B, Finstad D, Hatsukami D. Menstrual phase effects on smoking relapse. Addiction. 2008;103:809\u201321.","journal-title":"Addiction"},{"key":"525_CR79","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/jwh.2007.0415","volume":"17","author":"MJ Carpenter","year":"2008","unstructured":"Carpenter MJ, Saladin ME, Leinbach AS, Larowe SD, Upadhyaya HP. Menstrual phase effects on smoking cessation: a pilot feasibility study. Res J Women Health. 2008;17:293\u2013301.","journal-title":"Res J Women Health"},{"key":"525_CR80","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/j.1360-0443.2009.02758.x","volume":"104","author":"TR Franklin","year":"2009","unstructured":"Franklin TR, Allen SS. Influence of menstrual cycle phase on smoking cessation treatment outcome: a hypothesis regarding the discordant findings in the literature. Addiction. 2009;104:1941\u20132.","journal-title":"Addiction"},{"key":"525_CR81","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.addbeh.2010.01.003","volume":"35","author":"AM Allen","year":"2010","unstructured":"Allen AM, Allen SS, Lunos S, Pomerleau CS. Severity of withdrawal symptomatology in follicular versus luteal quitters: the combined effects of menstrual phase and withdrawal on smoking cessation outcome. Addict Behav. 2010;35:549\u201352.","journal-title":"Addict Behav"},{"key":"525_CR82","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1037\/a0038747","volume":"23","author":"AM Allen","year":"2015","unstructured":"Allen AM, Al\u2019Absi M, Lando H, Allen SS. Allopregnanolone association with psychophysiological and cognitive functions during acute smoking abstinence in premenopausal women. Exp Clin Psychopharm. 2015;23:22\u20138.","journal-title":"Exp Clin Psychopharm."},{"key":"525_CR83","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/ntr\/ntu262","volume":"17","author":"ME Saladin","year":"2015","unstructured":"Saladin ME, McClure EA, Baker NL, Carpenter MJ, Ramakrishnan V, Hartwell KJ, Gray KM. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res. 2015;17:398\u2013406.","journal-title":"Nicotine Tob Res"},{"key":"525_CR84","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.addbeh.2014.12.008","volume":"43","author":"AM Allen","year":"2015","unstructured":"Allen AM, Lunos S, Heishman SJ, Al\u2019Absi M, Hatsukami D, Allen SS. Subjective response to nicotine by menstrual phase. Addict Behav. 2015;43:50\u20133.","journal-title":"Addict Behav"},{"key":"525_CR85","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pbb.2017.11.001","volume":"165","author":"MM Moran-Santa Maria","year":"2018","unstructured":"Moran-Santa Maria MM, Sherman BJ, Brady K, Baker NL, Hyer JM, Ferland C, McRae-Clark AL. Impact of endogenous progesterone on reactivity to yohimbine and cocaine cues in cocaine-dependent women. Pharmacol Biochem Behav. 2018;165:63\u20139.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR86","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0091-3057(02)00818-3","volume":"73","author":"TL White","year":"2002","unstructured":"White TL, Justice AJ, de Wit H. Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav. 2002;73:729\u201341.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR87","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/ntr\/ntu183","volume":"17","author":"TR Franklin","year":"2015","unstructured":"Franklin TR, Jagannathan K, Wetherill RR, Johnson B, Kelly S, Langguth J, Mumma J, Childress AR. Influence of menstrual cycle phase on neural and craving responses to appetitive smoking cues in naturally cycling females. Nicotine Tob Res. 2015;17:390\u20137.","journal-title":"Nicotine Tob Res"},{"key":"525_CR88","first-page":"65","volume-title":"Women and addiction: a comprehensive handbook","author":"H Fox","year":"2009","unstructured":"Fox H, Sinha R. Stress, neuroendocrine response, and addiction in women. In: Brady KT, Back SE, Greenfield SF, editors. Women and addiction: a comprehensive handbook. New York (NY): The Guilford Press; 2009. p. 65\u201383."},{"key":"525_CR89","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12160-009-9093-8","volume":"37","author":"AW Blume","year":"2009","unstructured":"Blume AW, Marlatt GA. The role of executive cognitive functions in changing substance use: what we know and what we need to know. Ann Behav Med. 2009;37:117\u201325.","journal-title":"Ann Behav Med"},{"key":"525_CR90","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/sj.npp.1301465","volume":"33","author":"CC Streeter","year":"2007","unstructured":"Streeter CC, Terhune DB, Whitfield TH, et al. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology. 2007;33:827\u201336.","journal-title":"Neuropsychopharmacology"},{"key":"525_CR91","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psyneuen.2015.04.020","volume":"59","author":"A Berent-Spillson","year":"2015","unstructured":"Berent-Spillson A, Briceno E, Pinsky A, et al. Distinct cognitive effects of estrogen and progesterone in menopausal women. Psychoneuroendocrinology. 2015;59:25\u201336.","journal-title":"Psychoneuroendocrinology"},{"key":"525_CR92","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.psyneuen.2008.04.003","volume":"33","author":"S Sol\u00eds-Ortiz","year":"2008","unstructured":"Sol\u00eds-Ortiz S, Corsi-Cabrera M. Sustained attention is favored by progesterone during early luteal phase and visuo-spatial memory by estrogens during ovulatory phase in young women. Psychoneuroendocrinology. 2008;33:989\u201398.","journal-title":"Psychoneuroendocrinology"},{"key":"525_CR93","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0091-3057(01)00527-5","volume":"69","author":"M Sofuoglu","year":"2001","unstructured":"Sofuoglu M, Babb DA, Hatsukami DK. Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women. Pharmacol Biochem Behav. 2001;69:299\u2013304.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR94","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/sj.npp.1300887","volume":"31","author":"SM Evans","year":"2006","unstructured":"Evans SM, Foltin RW. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology. 2006;31:659\u201374.","journal-title":"Neuropsychopharmacology"},{"key":"525_CR95","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0091-3057(02)00716-5","volume":"72","author":"M Sofuoglu","year":"2002","unstructured":"Sofuoglu M, Babb DA, Hatsukami DK. Effects of progesterone treatment on smoked cocaine response in women. Pharmacol Biochem Behav. 2002;72:431\u20135.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR96","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.pbb.2004.05.004","volume":"78","author":"M Sofuoglu","year":"2004","unstructured":"Sofuoglu M, Mitchell E, Kosten TR. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol Biochem Behav. 2004;78:699\u2013705.","journal-title":"Pharmacol Biochem Behav"},{"key":"525_CR97","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.yhbeh.2010.04.003","volume":"58","author":"SC Reed","year":"2010","unstructured":"Reed SC, Levin FR, Evans SM. The effects of progesterone pretreatment on the response to oral d-amphetamine in women. Horm Behav. 2010;58:533\u201343.","journal-title":"Horm Behav"},{"key":"525_CR98","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.psyneuen.2012.12.022","volume":"38","author":"HC Fox","year":"2013","unstructured":"Fox HC, Sofuoglu M, Morgan PT, Tuit KL, Sinha R. The effects of exogenous progesterone on drug craving and stress arousal in cocaine dependence: impact of gender and cue type. Psychoneuroendocrinology. 2013;38:1532\u201344.","journal-title":"Psychoneuroendocrinology"},{"key":"525_CR99","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.psyneuen.2015.12.008","volume":"65","author":"V Milivojevic","year":"2016","unstructured":"Milivojevic V, Fox HC, Sofuoglu M, Covault J, Sinha R. Effects of progesterone stimulated allopregnanolone on craving and stress response in cocaine dependent men and women. Psychoneuroendocrinology. 2016;65:44\u201353.","journal-title":"Psychoneuroendocrinology"},{"key":"525_CR100","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.psyneuen.2017.09.012","volume":"86","author":"A Forray","year":"2017","unstructured":"Forray A, Gilstad-Hayden K, Suppies C, Bogen D, Sofuoglu M, Yonkers KA. Progesterone for smoking relapse prevention following delivery: a pilot, randomized, double-blind study. Psychoneuroendocrinology. 2017;86:96\u2013103.","journal-title":"Psychoneuroendocrinology"},{"key":"525_CR101","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.yhbeh.2010.12.009","volume":"59","author":"SC Reed","year":"2011","unstructured":"Reed SC, Evans SM, Bedi G, Rubin E, Foltin RW. The effects of oral micronized progesterone on smoked cocaine self-administration in women. Horm Behav. 2011;59:227\u201335.","journal-title":"Horm Behav"},{"key":"525_CR102","first-page":"453","volume":"15","author":"M Sofuoglu","year":"2007","unstructured":"Sofuoglu M, Poling J, Gonzale G, Oliveto A, Kosten TR. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study. Psychopharmacology. 2007;15:453\u201360.","journal-title":"Psychopharmacology"},{"key":"525_CR103","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S2215-0366(14)70333-5","volume":"1","author":"KA Yonkers","year":"2014","unstructured":"Yonkers KA, Forray A, Nich C, Carroll KM, Hine C, Merry BC, Shaw H, Shaw J, Sofuoglu M. Progesterone reduces cocaine use in postpartum women with a cocaine use disorder: a randomized, double-blind study. Lancet Psychiatry. 2014;1:360\u20137.","journal-title":"Lancet Psychiatry"},{"key":"525_CR104","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/ntr\/ntw156","volume":"18","author":"SS Allen","year":"2016","unstructured":"Allen SS, Allen AM, Lunos S, Tosun N. Progesterone and postpartum smoking relapse: a pilot double-blind placebo-controlled randomized trial. Nicotine Tob Res. 2016;18:2145\u201353.","journal-title":"Nicotine Tob Res"},{"key":"525_CR105","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/BF02246214","volume":"117","author":"E Schweize","year":"1995","unstructured":"Schweize E, Case WG, Garcia-Espana F, Greenblatt DJ, Rickels K. Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome. Psychopharmacology. 1995;117:424\u20139.","journal-title":"Psychopharmacology"},{"key":"525_CR106","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hup.2446","volume":"29","author":"V Milivojevic","year":"2014","unstructured":"Milivojevic V, Sinha R, Morgan P, Sofuoglu M, Fox H. Effects of endogenous and exogenous progesterone on emotional intelligence in cocaine dependent men and women who also abuse alcohol. Hum Psychopharmacol. 2014;29:589\u201398.","journal-title":"Hum Psychopharmacol"},{"key":"525_CR107","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsat.2012.12.007","volume":"45","author":"RK McHugh","year":"2013","unstructured":"McHugh RK, DeVito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013;45:38\u201343.","journal-title":"J Subst Abuse Treat"},{"key":"525_CR108","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1521-0391.2012.00232.x","volume":"21","author":"ME Saladin","year":"2012","unstructured":"Saladin ME, Gray KM, Carpenter MJ, LaRowe SD, DeSantis SM, Upadhyaya HP. Gender differences in craving and cue reactivity to smoking and negative affect\/stress cues. Am J Addict. 2012;21:210\u201320.","journal-title":"Am J Addict"},{"key":"525_CR109","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.steroids.2016.01.017","volume":"111","author":"J Weng","year":"2016","unstructured":"Weng J, Chung B. Nongenomic actions of neurosteroid pregnenolone and its metabolites. Steroids. 2016;111:54\u20139.","journal-title":"Steroids"},{"issue":"9","key":"525_CR110","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.biopsych.2013.01.032","volume":"73","author":"R Sinha","year":"2013","unstructured":"Sinha R, Jastreboff AM. Stress as a common risk factor for obesity and addiction. Biol Psychiatry. 2013;73(9):827\u201335.","journal-title":"Biol Psychiatry"},{"key":"525_CR111","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000358838","volume":"69","author":"C Hellgren","year":"2014","unstructured":"Hellgren C, Akerud H, Skalkidou A, Backstrom T, Sundstrom-Poromaa I. Low serum allopregnanolone is associated with symptoms of depression in late pregnancy. Neuropsychobiology. 2014;69:147\u201353.","journal-title":"Neuropsychobiology"},{"key":"525_CR112","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","volume":"390","author":"S Kanes","year":"2017","unstructured":"Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffmann E, Rubinow D, Jonas J, Paul S, Meltzer- Brody S. Brexanolone (SAGE-547 injection) in post-partum depression: a randomized controlled trial. Lancet. 2017;390:480\u20139.","journal-title":"Lancet"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-018-0525-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T18:18:19Z","timestamp":1604254699000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-018-0525-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1007\/s40263-018-0525-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"14 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Article preparation was supported by the Veterans Affairs New England Mental Illness Research, Education and Clinical Center, as well as a National Institute of Drug Abuse Training Grant T32-DA007238.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"MacKenzie Peltier and Mehmet Sofuoglu have no conflicts of interest directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}